Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Cognitive Dysfunction × Radiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Glioblastoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Pulmonary Fibrosis 1 Prostatic Neoplasms 1 Ototoxicity 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Ketosis 1 Insulin Resistance 1 Hearing Loss 1 Glioma 1 Germinoma 1 Esophageal Squamous Cell Carcinoma 1 Cognitive Dysfunction 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

lithium sulfate 1 Radiotherapy 1 Population Groups 1 Lithium 1 Drug Therapy 1 Diet, Mediterranean 1 Diet, Fat-Restricted 1 Chemoradiotherapy 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡